Skip to main content
. 2017 Aug 30;12(8):e0183977. doi: 10.1371/journal.pone.0183977

Table 2. Incidence of all-cause and malaria-specific illness1.

Immediate Delayed p2
All-cause illness visit
Period prevalence3 25/50 16/50 0.07
Incidence rate4 36/378 19/351 0.03
Malaria visit
Period prevalence 12/50 8/50 0.32
Incidence rate 13/378 9/351 0.49

1As assessed by sick-child visits to hospital clinic in the 56-day follow-up period of a recent iron therapy trial that compared the effect on iron status outcomes of iron started concurrently with vs. 28 days after antimalarial treatment in 100 Ugandan children 6–59 months old with malaria and anemia;

2P-value from chi-square for period prevalence and Poisson regression for incidence rate;

3Period prevalence = children with at least one sick visit in the follow-up period/children enrolled at beginning of study;

4Incidence rate = total number of sick visits in follow-up period/person weeks.